Literature DB >> 17314399

ERK activity and G1 phase progression: identifying dispensable versus essential activities and primary versus secondary targets.

Jessie Villanueva1, Yuval Yung, Janice L Walker, Richard K Assoian.   

Abstract

The ERK subfamily of MAP kinases is a critical regulator of S phase entry. ERK activity regulates the induction of cyclin D1, and a sustained ERK signal is thought to be required for this effect, at least in fibroblasts. We now show that early G1 phase ERK activity is dispensable for the induction of cyclin D1 and that the critical ERK signaling period is restricted to 3-6 h after mitogenic stimulation of quiescent fibroblasts. Similarly, early G1 phase ERK activity is dispensable for entry into S phase. Moreover, if cyclin D1 is expressed ectopically, ERK activity becomes dispensable throughout the G1 phase. In addition to its effect on cyclin D1, ERK activity is thought to contribute to the down-regulation of p27kip1. We found that this effect is restricted to late G1/S phase. Mechanistic analysis showed that the ERK effect on p27kip1 is mediated by Skp2 and is secondary to its effect on cyclin D1. Our results emphasize the importance of mid-G1 phase ERK activity and resolve primary versus secondary ERK targets within the G1 phase cyclin-dependent kinases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17314399      PMCID: PMC1838994          DOI: 10.1091/mbc.e06-10-0908

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  48 in total

1.  Loss of Rb overrides the requirement for ERK activity for cell proliferation.

Authors:  Giovanna M D'Abaco; Steven Hooper; Hugh Paterson; Christopher J Marshall
Journal:  J Cell Sci       Date:  2002-12-01       Impact factor: 5.285

2.  Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action.

Authors:  Michael P Markey; Steven P Angus; Matthew W Strobeck; Sarah L Williams; Ranjaka W Gunawardena; Bruce J Aronow; Erik S Knudsen
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

3.  Activation of cyclin D1 expression by the ERK5 cascade.

Authors:  Roseann Mulloy; Sara Salinas; Alexandre Philips; Robert A Hipskind
Journal:  Oncogene       Date:  2003-08-21       Impact factor: 9.867

4.  Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: correlation between late phase activation and mitogenicity.

Authors:  S Meloche; K Seuwen; G Pagès; J Pouysségur
Journal:  Mol Endocrinol       Date:  1992-05

5.  Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes.

Authors:  J DeGregori; T Kowalik; J R Nevins
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

Review 6.  The retinoblastoma protein and cell cycle control.

Authors:  R A Weinberg
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

Review 7.  G1 phase progression: cycling on cue.

Authors:  C J Sherr
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

8.  Antimitogenesis linked to regulation of Skp2 gene expression.

Authors:  Sheryl A Stewart; Devashish Kothapalli; Yuval Yung; Richard K Assoian
Journal:  J Biol Chem       Date:  2004-05-04       Impact factor: 5.157

9.  Identification of target genes of the p16INK4A-pRB-E2F pathway.

Authors:  Richard Vernell; Kristian Helin; Heiko Müller
Journal:  J Biol Chem       Date:  2003-08-15       Impact factor: 5.157

10.  Estrogens down-regulate p27Kip1 in breast cancer cells through Skp2 and through nuclear export mediated by the ERK pathway.

Authors:  James S Foster; Romaine I Fernando; Noriko Ishida; Keiichi I Nakayama; Jay Wimalasena
Journal:  J Biol Chem       Date:  2003-08-06       Impact factor: 5.157

View more
  40 in total

1.  ERK crosstalks with 4EBP1 to activate cyclin D1 translation during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.

Authors:  Jennifer D Cohen; Jaime M C Gard; Raymond B Nagle; Justin D Dietrich; Terrence J Monks; Serrine S Lau
Journal:  Toxicol Sci       Date:  2011-08-02       Impact factor: 4.849

2.  Differential activation of ERK and Rac mediates the proliferative and anti-proliferative effects of hyaluronan and CD44.

Authors:  Devashish Kothapalli; James Flowers; Tina Xu; Ellen Puré; Richard K Assoian
Journal:  J Biol Chem       Date:  2008-09-19       Impact factor: 5.157

3.  Dahuang zhechong pill containing serum inhibited platelet-derived growth factor-stimulated vascular smooth muscle cells proliferation by inducing G1 arrest partly via suppressing protein kinase C α-extracellular regulated kinase 1/2 signaling pathway.

Authors:  Na Liu; Jun-tian Liu; Yuan-yuan Ji; Pei-pei Lu
Journal:  Chin J Integr Med       Date:  2011-04-26       Impact factor: 1.978

4.  Prolactin-induced protein is required for cell cycle progression in breast cancer.

Authors:  Ali Naderi; Marion Vanneste
Journal:  Neoplasia       Date:  2014-04       Impact factor: 5.715

5.  Constitutively active RhoA inhibits proliferation by retarding G(1) to S phase cell cycle progression and impairing cytokinesis.

Authors:  Pierre Morin; Cristina Flors; Michael F Olson
Journal:  Eur J Cell Biol       Date:  2009-06-09       Impact factor: 4.492

6.  ERK1/2 MAP kinases promote cell cycle entry by rapid, kinase-independent disruption of retinoblastoma-lamin A complexes.

Authors:  Javier Rodríguez; Fernando Calvo; José M González; Berta Casar; Vicente Andrés; Piero Crespo
Journal:  J Cell Biol       Date:  2010-11-29       Impact factor: 10.539

7.  The absence of caveolin-1 increases proliferation and anchorage- independent growth by a Rac-dependent, Erk-independent mechanism.

Authors:  Ana Cerezo; Marta C Guadamillas; Jacky G Goetz; Sara Sánchez-Perales; Eric Klein; Richard K Assoian; Miguel A del Pozo
Journal:  Mol Cell Biol       Date:  2009-07-20       Impact factor: 4.272

Review 8.  Melanoma and the tumor microenvironment.

Authors:  Jessie Villanueva; Meenhard Herlyn
Journal:  Curr Oncol Rep       Date:  2008-09       Impact factor: 5.075

9.  P19 H-ras induces G1/S phase delay maintaining cells in a reversible quiescence state.

Authors:  Maria Camats; Mariette Kokolo; Kate J Heesom; Michael Ladomery; Montse Bach-Elias
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

10.  Erk1/2 MAP kinases are required for epidermal G2/M progression.

Authors:  Phillip A Dumesic; Florence A Scholl; Deborah I Barragan; Paul A Khavari
Journal:  J Cell Biol       Date:  2009-05-04       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.